Genetic and epigenetic predictors of responsiveness to treatment in RA. (Q38188860)

30 August 2017

Genetic and epigenetic predictors of responsiveness to treatment in RA. (English)

1 reference

30 August 2017

3

1 reference

30 August 2017

Darren Plant

1

1 reference

30 August 2017

Anthony G Wilson

series ordinal

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

18 February 2014

1 reference

Nature Reviews Rheumatology

30 August 2017

1 reference

30 August 2017

10

1 reference

30 August 2017

6

1 reference

30 August 2017

329-337

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2014.16

30 August 2017

0 references

cites work

Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Reduction of long-term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: results from the Norfolk Arthritis Register.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Cancer biomarkers--an invitation to the table

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Association of rheumatoid arthritis risk alleles with response to anti-TNF biologics: results from the CORRONA registry and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Tobacco-smoking-related differential DNA methylation: 27K discovery and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Epigenetic differences arise during the lifetime of monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Charting a dynamic DNA methylation landscape of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Chromatin modifications and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

The influence of aging, environmental exposures and local sequence features on the variation of DNA methylation in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Nutritional factors and gender influence age-related DNA methylation in the human rectal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

DNA hypomethylation in rheumatoid arthritis synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

DNA methylome signature in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Principles and challenges of genomewide DNA methylation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

DNA hypomethylation in inflammatory arthritis: reversal with methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Genome-scale case-control analysis of CD4+ T-cell DNA methylation in juvenile idiopathic arthritis reveals potential targets involved in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Clinical and prognostic significance of protocadherin-10 (PCDH10) promoter methylation in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

TNF-alpha-308 G/A polymorphism and responsiveness to TNF-alpha blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Keeping up NF-kappaB appearances: epigenetic control of immunity or inflammation-triggered epigenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Epigenetic regulation of tumor necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Genomic maps and comparative analysis of histone modifications in human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

DNA methylation arrays as surrogate measures of cell mixture distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

ChIP-seq: advantages and challenges of a maturing technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Development of a multi-biomarker disease activity test for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Personal omics profiling reveals dynamic molecular and medical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Optimalization of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

The ascent of acetylation in the epigenetics of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

S-Adenosylmethionine and methylation

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

31 March 2020

12 December 2020

Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Transcription regulatory polymorphism -43T>C in the 5'-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2014.16

Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis.

31 March 2020

1 reference

12 December 2020

Molecular biology of 5,10-methylenetetrahydrofolate reductase

1 reference

12 December 2020

Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy

1 reference

12 December 2020

Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2014.16

1 reference

Dimensions Publication ID

30 August 2017

0 references

1 reference